2025三季度财报发布，膳食营养补充剂（VDS）龙头企业汤臣倍健交出复苏答卷：营收、净利润同比双增，第三 季度营收同比增长23.45%，且前三季度利润同比恢复增长，经营能力逐季改善。 汤臣倍健董事长梁允超在30周年庆典上说道："不在'品牌和产品创新'的餐桌上，就在'渠道'的菜单上。"业绩修复 的背后，是一场以用户价值为核心、贯穿研发、品牌、渠道全链路的价值链深度变革，更是汤臣倍健从行业变局 中探索新增长路径的必然结果。 行业重构期，锚定用户价值打破迷局 面对消费变局，不同行业都在求突围，但唯有企业经营数据才是见真章的"试金石"。 汤臣倍健的改革，不是为了应对业绩下跌的临时之举，而是长期主义战略的延续和深化。 VDS行业增速放缓，线下药店作为传统基本盘，一边受医保政策影响，一边面临客流下滑，品牌和渠道不再紧密 合作，反而变成利益博弈；线上渠道则陷入低价、同质化混战，企业盈利空间被挤压。 与此同时，消费需求在升级。普通消费者看重"同价位里品质最好"的质价比，高端用户则愿意为"实打实的科学功 能"和专业价值买单。过去那种"一刀切"的产品供给，跟不上市场需求的分化节奏。 危中有机，行业结构性机会依然清晰。2024年中 ...

Core Insights - The core viewpoint of the article emphasizes that the operational data of companies serves as a true measure of their performance amidst changing consumer dynamics, with Tongrentang's (汤臣倍健) recent financial results showcasing a recovery in revenue and net profit [1][12] Group 1: Company Performance - Tongrentang reported a 23.45% year-on-year increase in revenue for Q3 2025, with profits also showing recovery in the first three quarters [1][12] - The company launched 71 new products in the first three quarters of 2025 and holds 487 domestic and international patents, indicating a strong focus on innovation [4][12] Group 2: Strategic Transformation - The company's reform is a continuation of its long-term strategy rather than a temporary response to declining performance, focusing on user value and breaking away from past dependencies [3][12] - Tongrentang's "strong technology transformation" strategy aims to enhance product strength and technological competitiveness, with a commitment to user needs as the core of its growth path [3][4] Group 3: Market Dynamics - The VDS industry is experiencing a slowdown, with traditional offline pharmacies facing challenges from policy changes and reduced foot traffic, while online channels are struggling with price wars and homogenization [3][6] - Despite these challenges, the VDS market is projected to grow by 3.7% in 2024, outpacing the 1.7% growth of the fast-moving consumer goods market [3] Group 4: Product and Channel Strategy - Tongrentang is building a dual-engine product matrix of "basic mass products + segmented functional products" to address both general market needs and specialized high-value areas [9][10] - The company is shifting its channel strategy from a focus on quantity to a model of empowerment and profit-sharing, enhancing collaboration with pharmacies and leveraging digital tools for efficient operations [10][11] Group 5: Brand Positioning - Tongrentang is enhancing its brand image through partnerships in scientific exploration and health initiatives, reinforcing its trust and credibility in the market [11][12] - The company aims to create a complete value chain centered on user health, integrating R&D, branding, and channels to meet real consumer needs [12][13]

Summary of Industry and Company Insights from Conference Call Records Industry: Baijiu (Chinese Liquor) Key Points: - The overall performance of the baijiu industry in Q3 was under pressure, with most companies experiencing a decline in net profit, particularly those with significant revenue drops. [1][7] - Moutai maintained a stable performance with a 7% revenue increase, despite a drop in batch prices from 1,760 RMB to around 1,670 RMB, reflecting a more than 20% year-on-year decline. [1][10] - Wuliangye saw a significant revenue decline of 52% and a profit drop of 65%, indicating substantial pressure on its performance. [1][4] - Luzhou Laojiao performed better than expected, with effective strategies in place, although external environmental factors need to be monitored. [1][6] - The second-tier brand Fenjiu showed stable performance, with the Qinghua series growing by 9-10%, while Qinghua 30 experienced a decline of 20-30%. [1][5] - The overall baijiu sector is expected to continue adjustments in Q4 in preparation for the Spring Festival, which is a critical sales period. [1][8] Industry: Dairy Products Key Points: - The dairy sector faced weak terminal demand in Q3, with Yili's liquid milk revenue declining by 8.8%, while New Dairy achieved double-digit growth. [1][12] - The outlook for Q4 remains challenging, with expectations of continued pressure on liquid milk demand due to weak consumer confidence. [1][13] - New Dairy and Miaokelando are expected to maintain good growth through product innovation and market expansion. [1][13][14] Industry: Soft Drinks Key Points: - The soft drink industry showed stable performance in Q3, driven by strong travel demand and the introduction of new products. [1][15] - Dongpeng Beverage reported a 30.4% revenue increase, benefiting from new product launches, while competitors like Master Kong and Uni-President experienced revenue declines. [1][15][16] - Long-term growth prospects for Dongpeng and Nongfu Spring are viewed positively, while Master Kong and Uni-President are considered defensive dividend investment options. [1][18] Industry: Frozen Foods Key Points: - The frozen food sector is showing signs of stabilization, with demand not expected to worsen significantly. [1][20] - Leading companies are reducing expenditure, leading to some profit recovery, although growth rates remain modest. [1][20] - The industry is at a bottom turning point, with expectations for improvement in restaurant demand. [1][20] Industry: Snacks Key Points: - The snack sector saw slight revenue growth but at a slower pace, with rapid growth in bulk snack channels. [1][21] - New retail channels like Sam's Club are contributing significantly to revenue growth, despite some short-term impacts from public sentiment. [1][21] - The performance of key brands like Yanjin and Youyou has improved, indicating better operational efficiency and profitability. [1][25] Industry: Meat Products Key Points: - The meat product sector is considered a defensive dividend segment, with companies like Shuanghui Development and WH Group showing stable performance. [1][22] - Shuanghui's meat product sales remained steady, with a target of 30% growth in new channels for the upcoming year. [1][23] - WH Group's U.S. market performance was stable, with expectations for relatively stable pork prices in 2026. [1][24] Overall Market Performance Key Points: - The food and beverage sector has underperformed compared to the CSI 300 index, with a 5.5% decline as of October 31, 2025. [1][9] - The baijiu sector's valuation has decreased, with a forecasted P/E ratio of 18.9 times, lower than historical averages. [1][9] - Fund holdings in the baijiu sector have decreased, indicating potential for future capital inflow if demand improves. [1][9]

Core Insights - The company reported a significant improvement in its financial performance for Q3 2025, with a notable increase in both revenue and net profit compared to the previous quarters [1][2] - The overall revenue for the first three quarters of 2025 decreased by 14.27% year-on-year, but Q3 alone showed a 23.45% increase, indicating a recovery trend [1][2] Financial Performance - For Q1-Q3 2025, the company achieved a total revenue of 4.915 billion yuan, with a net profit of 907 million yuan, and a non-recurring net profit of 827 million yuan [1] - In Q3 2025, the company reported revenue of 1.383 billion yuan, a year-on-year increase of 23.45%, and a net profit of 171 million yuan, reflecting a substantial year-on-year increase of 861.91% [1] - The gross margin and net margin for Q3 2025 were 68.56% and 13.07%, respectively, showing improvements of 3.25 percentage points and 14.68 percentage points year-on-year [2] Brand Performance - The main brand,汤臣倍健, generated revenue of 2.676 billion yuan in the first three quarters of 2025, down 16% year-on-year, while健力多 saw a revenue of 574 million yuan, down 18% year-on-year [1] - The overseas brand LSG achieved revenue of 720 million yuan, marking a 14% year-on-year increase [1] Operational Efficiency - The company has been actively enhancing its operational efficiency both online and offline, leading to quality growth across various channels [2] - The expense ratios for sales, management, R&D, and financial costs in Q3 2025 were 43.98%, 10.54%, 1.80%, and -0.32%, respectively, with significant reductions in sales and management expense ratios [2] Future Outlook - The company aims to adopt a "re-entrepreneurial" mindset in 2026, focusing on product innovation and global market expansion [2] - Projections indicate that the company could achieve net profits of 784 million yuan, 889 million yuan, and 999 million yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 20%, 13%, and 12% [2]

Group 1: Online Channel Development - The e-commerce channel has been a significant driver of industry growth, with Douyin being the largest platform for online sales in the VDS sector [2] - Traditional e-commerce platforms like Tmall and JD.com maintain a high market share, and the company is committed to a multi-channel strategy [2] - Continuous optimization in product and operations will enhance social media penetration and adapt to consumer preferences [2] Group 2: Organizational Structure and Future Plans - No major adjustments to the organizational structure are anticipated in the coming year, following two years of optimization focused on brand business units [2][4] - The company aims to create independent closed loops around brands, covering the entire value chain from product development to sales [2] Group 3: Offline Channel Strategy - The pharmacy channel is undergoing structural adjustments after rapid expansion, but its specialized service capabilities remain irreplaceable [3] - The company plans to accelerate the digital infrastructure for pharmacies and explore new delivery models to create additional value for consumers and partners [3] Group 4: Product Innovation and Market Strategy - The company recognizes the increasing demand for diversified and personalized products, leading to regular upgrades of core product categories [4] - A focus on product innovation and a "re-entrepreneurial" mindset will guide the company's strategy for 2026, emphasizing brand investment and global market expansion [5]

Core Viewpoint - The leading dietary supplement company, Tongrentang, reported significant growth in Q3 2023, with revenue reaching 1.383 billion yuan, a year-on-year increase of 23.45%, and net profit attributable to shareholders at 170 million yuan, up 861.91% [1] Financial Performance - In Q3 2023, Tongrentang achieved a revenue of 1.383 billion yuan, marking a 23.45% increase year-on-year - The net profit attributable to shareholders was 170 million yuan, reflecting an 861.91% increase year-on-year - The non-recurring net profit was approximately 133 million yuan, showing a 652.64% year-on-year growth - For the first nine months of 2023, the net profit attributable to shareholders increased by 4.45% compared to the same period last year, while the non-recurring net profit rose by 2.44% [1] Product Innovation - Tongrentang launched 71 new products in the first three quarters of 2023, with new product sales accounting for over 20% for the first time - The company is focusing on user needs, with 68% of consumers under 35 preferring products based on "scenario-based functions" rather than brand alone [3] - The new "multi-layer tablet" product achieved sales of over 10 million yuan within 45 days of launch, showcasing effective market positioning [3] - The company is adapting to industry innovation trends, shifting from merely adding new ingredients to ensuring scientific validation and scenario relevance [4] Channel Reconstruction - Tongrentang is addressing the common industry issue of online and offline channel conflicts by implementing separate inventory strategies for each channel - The offline strategy targets the mass market with high cost-performance products, while the online strategy focuses on professional, niche, and high-end products [7] - The company is enhancing channel service by training pharmacy staff to become "health consultants," improving both user experience and store revenue [8] Industry Insights - The dietary supplement (VDS) industry is experiencing a "Matthew Effect," where leading brands are gaining market share through R&D and channel strategies, while smaller brands struggle with price competition [9] - The market share of the top five brands in the VDS industry is projected to increase to 38% by 2025, up 6 percentage points from 2023 [10] - Tongrentang's international business has become a new growth point, with overseas revenue reaching 720 million yuan, a year-on-year increase of 13.64% [10] Future Outlook - The company plans to adopt a "re-entrepreneurial" mindset over the next five years, focusing on long-term brand investment despite short-term profit sacrifices [11] - Tongrentang emphasizes the importance of responding quickly to user needs and maintaining operational quality to sustain growth in a challenging market [13]

25Q4 收入端有望保持较高增长，2026 年聚焦产品创新全线出击。25Q2-Q3 公司新品陆续上市，线上推 出高价格带产品、线下完善大众价格带布局，丰富消费者选择；且公司持续强化用户资产运营能力，提 升销售转化，预计25Q4 收入端在低基数下仍有望实现较高增长。在2025 年企稳的基础上，2026 年公司 将以"再创业"心态全线出击，聚焦产品创新、确保长远健康的品牌投入，加快全球市场拓展。 投资建议：因行业竞争激烈，略下调盈利预测，预期2025-2027 年公司实现归母净利润 7.9/9.2/10.3 亿元 （前次8预.3/测9.为7/10.9 亿元），同比+20.4%/16.9%/11.7%，当前股P价E 为对应27/23/21x。 风险提示：电商渠道竞争加剧，新品培育不及预期，药店人流量持续下滑。 事件：公司发布2025 年三季报，前三季度实现营收49.2 亿元，同比-14.3%；归母净利润9.1 亿元，同比 +4.5%；扣非归母净利润8.3 亿元，同比+2.4%。其中25Q3 实现营收13.8 亿元，同比+23.5%；归母净利 润1.7 亿元，同比+861.9%；扣非归母净利润1.3 亿元，同比+65 ...

公司研究 证 券 研 究 报 告 汤臣倍健（300146）2025 年三季报点评 中性（维持） 全面调整，成效初显 事项： ❖ 公司发布 2025 年三季报。25 年前三季度实现营收 49.15 亿元，同比-14.27%； 归母净利润 9.07 亿元，同比+4.45%；扣非归母净利润 8.27 亿元，同比+2.44%。 单 Q3 实现营收 13.83 亿元，同比+23.45%；归母净利润 1.71 亿元，去年同期 为-0.22 亿元；扣非归母净利 1.33 亿元，去年同期为-0.24 亿元。 评论： ❖ 风险提示: 行业竞争加剧，销售不达预期，监管政策收紧，食品安全风险等 证券分析师：董广阳 [ReportFinancialIndex] 主要财务指标 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业总收入(百万) | 6838 | 6271 | 6624 | 6932 | | 同比增速(%) | -27.3% | -8.3% | 5.6% | 4.7% | | 归母净利润(百万) | 653 | 811 | 960 ...

Key Insights - The report highlights significant changes in fund allocation during Q3 2025, with a notable increase in equity positions and a shift towards AI and new energy sectors, while consumer sectors faced reductions [8][9][10] - The performance of various industries shows a mixed trend, with coal and machinery sectors experiencing fluctuations in revenue and profit margins, while technology and communication sectors demonstrate robust growth [24][26][29][35][40] Fund Allocation Insights - Fund sizes increased significantly, with a 20% rise in active fund products, driven by a strong A-share market performance, particularly a 20% increase in the CSI 800 index [8] - There is a reinforced trend of reducing mainboard allocations while increasing investments in emerging sectors, with the STAR Market allocations reaching new highs [9] - AI and new energy sectors are leading the allocation trends, while consumer sectors like home appliances and automobiles are seeing widespread reductions [9][10] Industry Performance Insights - The coal industry is facing challenges, with companies like Pingmei and Lu'an reporting significant declines in revenue and profit due to structural changes in sales, although Q4 is expected to see recovery due to rising coal prices [35][44] - The machinery sector, represented by companies like Rongzhi Rixin, is experiencing substantial growth, with a 13.9% increase in revenue and an impressive 890% rise in net profit year-on-year [26] - The communication sector, particularly companies like New Yisheng, reported a 152.5% year-on-year revenue increase, driven by strong demand for optical communication products [24] Company-Specific Insights - Bull Group's revenue decline is narrowing, with healthy cash flow, and the company is expected to maintain a "buy" rating based on future profit projections [20] - Hikvision is showing signs of recovery with stable profits and cash flow, supported by advancements in AI technology [47] - Huabao New Energy is facing short-term profit pressure due to tariffs but maintains strong growth potential with a projected increase in net profit over the next few years [29]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company has shown significant improvement in Q3 performance, with a notable increase in revenue and profitability driven by new product launches [5][6] - The company is expected to narrow the revenue decline for the full year 2025, with a focus on product innovation and channel reform [8] Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved revenue of 4.92 billion yuan, a year-on-year decrease of 14.3%, while net profit attributable to shareholders was 910 million yuan, an increase of 4.5% [5] - In Q3 2025, revenue reached 1.38 billion yuan, a year-on-year increase of 23.5%, and net profit turned positive at 170 million yuan [5][6] Brand and Channel Analysis - The main brand "汤臣倍健" generated revenue of 2.676 billion yuan in the first three quarters, down 16.22% year-on-year, while the "健力多" brand saw revenue of 574 million yuan, down 17.76% [6] - Online channel revenue was 2.388 billion yuan, a decrease of 7.67%, showing a significant improvement compared to the 13.78% decline in the first half of the year [6] Profitability and Cost Management - The gross margin for the first three quarters was 68.55%, an increase of 0.63 percentage points year-on-year, attributed to the launch of high-value new products [7] - The net profit margin reached 19.21% for the first three quarters, an increase of 4.17 percentage points year-on-year [7] Future Outlook - The company anticipates a single-digit revenue decline for the full year 2025, with ongoing product innovation and channel optimization expected to drive recovery [8] - New product contributions have approached 20% of total revenue in the first three quarters, indicating a positive trend for future growth [8] Earnings Forecast and Valuation - The forecast for net profit attributable to shareholders for 2025-2027 has been adjusted to 688 million, 798 million, and 879 million yuan, respectively, reflecting a downward revision of 13% for 2025 [9][10] - The company is projected to maintain a leading position in the dietary supplement industry, with a PE ratio of 31x for 2025 [9][10]